SMITH & NEPHEW PLC -SPON ADR (SNN)
US83175M2052 - ADR
December 20th Options Now Available For Smith & Nephew (SNN)
Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention
Smith+Nephew signs exclusive distribution agreement to provide unique NAVBIT SPRINT™ solution in Australia
Compact, single-use, and simple-to-use technology offers surgeons a fast, reliable navigation solution for hip arthroplasty Smith+Nephew (LSE:SN,...
Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the review of medical technologies guidance from the UK National...
Oversold Conditions For Smith & Nephew (SNN)
Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce the launch of its RENASYS EDGE Negative Pressure Wound...
Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner
Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has been named the Preferred Sports Medicine Technology Partner...
7 Robotic Surgery Stocks to Buy for the Future of Healthcare
Discover seven robotic surgery stocks primed for growth as the industry evolves. Unveil opportunities in a market set to double by 2033.
Smith & Nephew Breaks Below 200-Day Moving Average - Notable for SNN
Smith+Nephew and U.S. Army Institute of Surgical Research to engage in Master Cooperative Research and Development Agreement
Smith & Nephew reports Q4 results (NYSE:SNN)
Smith & Nephew surpasses expectations with Q4 revenue of $1.45B (+5.8% YoY), beating estimates by $20M.
3 Millionaire-Maker Robotics Stocks to Buy in February 2024
Jump into the future with top robotics stocks poised for explosive growth. Discover the potential for massive returns.
Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting
Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces full commercial availability of its AETOS Shoulder System in the...
Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting
Smith+Nephew (LSE: SN, NYSE:SNN), the global medical technology company, announces it will provide a glimpse into the future at AAOS 2024. With a first...
Smith+Nephew unveils expanded Sports Medicine portfolio to enable biological healing at AAOS 2024 Annual Meeting
Smith+Nephew unveils expanded Sports Medicine portfolio to enable biological healing at AAOS 2024 Annual Meeting
12 February 2024 Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the premiere of its newly acquired CARTIHEAL◊...
First Week of SNN September 20th Options Trading
Bullish Two Hundred Day Moving Average Cross - SNN
Australia’s approach to musculoskeletal injury care and reimbursement demands rethink: Report
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces a new report examining musculoskeletal injury care and...
New study confirms Smith+Nephew’s REGENETEN™ Bioinductive Implant reduces full-thickness rotator cuff re-tear rates¹ by 68%
New study confirms Smith+Nephew’s REGENETEN™ Bioinductive Implant reduces full-thickness rotator cuff re-tear rates¹ by 68%
First published randomized controlled trial for market-leading implant demonstrates impressive outcomes for rotator cuff tears ...
Smith & Nephew appoints John Rogers as CFO (NYSE:SNN)
Smith & Nephew appoints John Rogers as CFO. Q3 revenue reaches $1.36B with underlying growth of 7.7%.
Smith & Nephew is Now Oversold (SNN)
Smith+Nephew opens new state-of-the-art surgical innovation and training centre in the heart of Munich
/PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company specialising in orthopaedics, advanced wound management and sports...
Smith+Nephew opens new state-of-the-art surgical innovation and training centre in the heart of Munich
/CNW/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company specialising in orthopaedics, advanced wound management and sports medicine,...
First Week of October 20th Options Trading For Smith & Nephew (SNN)
(NYSE:SNN)
Smith & Nephew press release (SNN): 1H Non-GAAP EPS of $0.35.Revenue of $2.73B (+5.0% Y/Y).Our first half revenue was $2,734 million (H1 2022: $2,600 million), up 7.3% on an...